12/17
08:54 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
11/15
09:34 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $12.00 to $11.00. They now have a "buy" rating on the stock.
11/14
08:22 am
tlsi
TriSalus Reports Q3 2024 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
TriSalus Reports Q3 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/14
08:00 am
tlsi
TriSalus Reports Q3 2024 Financial Results and Provides Business Update
High
Report
TriSalus Reports Q3 2024 Financial Results and Provides Business Update
11/13
07:37 am
tlsi
TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
11/12
07:49 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
11/11
08:08 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $11.00 price target on the stock.
Medium
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $11.00 price target on the stock.
11/11
07:00 am
tlsi
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
Medium
Report
TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
11/7
07:00 am
tlsi
TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
Low
Report
TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
10/31
08:00 am
tlsi
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
Low
Report
TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
10/26
06:23 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Northland Capmk to a "strong-buy" rating.
Low
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) was upgraded by analysts at Northland Capmk to a "strong-buy" rating.
10/25
09:38 am
tlsi
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $12.50 price target on the stock.
Low
Report
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $12.50 price target on the stock.
10/14
04:05 pm
tlsi
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit